Endemic bacteriophages: a cautionary tale for evaluation of bacteriophage therapy and other interventions for infection control in animals by Andrew M Kropinski et al.
Kropinski et al. Virology Journal 2012, 9:207
http://www.virologyj.com/content/9/1/207RESEARCH Open AccessEndemic bacteriophages: a cautionary tale for
evaluation of bacteriophage therapy and other
interventions for infection control in animals
Andrew M Kropinski1,2, Erika J Lingohr1, Dianne M Moyles2, Shivani Ojha1, Amanda Mazzocco1, Yi-Min She3,
Susan J Bach4, Erica A Rozema5,6,7, Kim Stanford6, Tim A McAllister7 and Roger P Johnson1*Abstract
Background: One of the most effective targets for control of zoonotic foodborne pathogens in the farm to fork
continuum is their elimination in food animals destined for market. Phage therapy for Escherichia coli O157:H7 in
ruminants, the main animal reservoir of this pathogen, is a popular research topic. Since phages active against this
pathogen may be endemic in host animals and their environment, they may emerge during trials of phage therapy
or other interventions, rendering interpretation of trials problematic.
Methods: During separate phage therapy trials, sheep and cattle inoculated with 109 to 1010 CFU of E. coli O157:H7
soon began shedding phages dissimilar in plaque morphology to the administered therapeutic phages. None of
the former was previously identified in the animals or in their environment. The dissimilar “rogue” phage was
isolated and characterized by host range, ultrastructure, and genomic and proteomic analyses.
Results: The “rogue” phage (Phage vB_EcoS_Rogue1) is distinctly different from the administered therapeutic
Myoviridae phages, being a member of the Siphoviridae (head: 53 nm; striated tail: 152 x 8 nm). It has a 45.8 kb
genome which is most closely related to coliphage JK06, a member of the “T1-like viruses” isolated in Israel.
Detailed bioinformatic analysis reveals that the tail of these phages is related to the tail genes of coliphage lambda.
The presence of “rogue” phages resulting from natural enrichments can pose problems in the interpretation of
phage therapeutic studies. Similarly, evaluation of any interventions for foodborne or other bacterial pathogens in
animals may be compromised unless tests for such phages are included to identify their presence and potential
impact.
Keywords: Escherichia coli O157:H7, VTEC, Phage therapy, Phage ecology, Genome, Proteome, Bioinformatics,
Morphology, Electron microscopyBackground
Foodborne microbial pathogens are a significant cause
of morbidity and mortality globally, with a recent esti-
mate placing the annual number of cases of foodborne
disease at 11 million in Canada alone [1]. In an analysis
accounting for under-reporting [2], estimates of the an-
nual community rates of infections caused by the zoo-
notic foodborne pathogens Salmonella, Campylobacter
and verotoxigenic E. coli in Canada are as high as 7, 19* Correspondence: Roger.Johnson@phac-aspc.gc.ca
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reproduction in any medium, provided the orand 3 per 1,000 population, respectively. While most indi-
viduals recover from these infections, longer-term health
outcomes may include haemolytic uremic syndrome
(HUS), chronic renal insufficiency, chronic arthritis, irrit-
able bowel syndrome and Guillain-Barré syndrome.
The economic impact of these illnesses can be very
high, with the annual cost to treat the short-term effects
of acute gastrointestinal illness in Canada estimated to
be about $1,089 CAD per case, with annual total costs
exceeding $3.7 billion [3]. In the province of Ontario
alone, the annual economic impact associated with
human illness due to E. coli O157:H7 in ground beef has
been estimated as $24.8 million [4]. Therefore, reducingal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Photomicrograph of plaques produced by phage
Rogue1 on lawns of E. coli O157:H7 R508N.
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have significant public health and economic impacts.
Given these impacts, substantial effort has been direc-
ted at controlling zoonotic foodborne pathogens early
in the farm to fork continuum. Bacteriophages have been
proposed, and used, as biocontrol agents in food animals
and foods (reviewed in [5-13]. Recently, their potential as
therapeutics convinced the United States Food and Drug
Administration to allow the use of Intralytix’s anti-Listeria
monocytogenes phage cocktail ListShield in meat products
[14]. Similarly, LISTEXTM (a phage preparation from
MICREOS Food Safety (Netherlands)) was approved as
GRAS (Generally Recognized As Safe) and is currently
being used in the ready-to-eat food industry in North
America. OmniLytics (Salt Lake City, UT) has obtained
approval from the United States Department of Agricul-
ture/Food Safety & Inspection Service for a hide-washing
solution containing phage active against E. coli O157:H7;
and more recently for Salmonella.
The process of bacteriophage therapy for pathogen
control is dependent upon the selection of broad-range
lytic bacteriophages with rapid adsorptive properties
and strong cell killing activity. Furthermore, the phages
must be capable of being mass produced, stable during
preparation and storage, and shown to be safe and ef-
fective upon application. Like many other interventions
such as vaccines, probiotics and other antimicrobials,
bacteriophage therapy for control of foodborne zoonotic
pathogens is often evaluated in experimentally or natur-
ally infected animals. During such evaluations it is im-
perative to ensure that any factors that may confound
assessment of the true effectiveness of the tested inter-
vention are carefully monitored. It is now well known
that animals and their environments are natural niches
of bacteriophages. For example, E. coli O157:H7 bacter-
iophages are ubiquitous in feedlot cattle and their envir-
onment, and at very high prevalences when identified by
phage enrichment using rather simple screening tests
[15-17]. Consequently, it has been recommended that
before in vivo pathogen eradication studies using phage
or any other regime, test animals should be enrichment
screened for phages to avoid erroneous results [15]. In
2009, our group first described the appearance of lytic
phages distinct from therapeutic phages administered to
steers preinoculated with 5 x 1010 CFU of a mixture of
E. coli O157:H7 strains [18]. These “rogue phages” pro-
duced larger plaques than the therapeutic phages and
were morphologically distinct. Also, they appeared to be
endemic, since the same phages had been isolated from E.
coli O157:H7-inoculated sheep in a preliminary phage
therapy trial on the same facility four years earlier. In the
current manuscript we describe the physiological, genetic
and proteomic characteristics of one of these viruses, and
comment on the potential impact of endemic phages onevaluation of phage therapy and other interventions for
control of bacterial infections.
Results
Isolation, plaque morphology and host-range of
vB_EcoS_Rogue
Three isolates of the rogue phage were successfully pro-
pagated and enumerated on strain R508N using standard
protocols [19]. Their plaques averaged 4 mm in diameter
wide opalescent zones with around 1 mm centres
of clear lysis (Figure 1), closely resembling the rogue
phage identified in cattle [18] as compared to the 1-2 mm
clear lytic plaques of the administered phages. In host-
range studies, the three rogue phage isolates possessed es-
sentially identical host ranges, being virulent for most
tested strains except for the two non-O157 strains and one
E. coli O157:H7 PT1 strain (Table 1). All three gave an
identically sized amplicon upon PCR analysis using primer
pairs directed to the putative tail fibre gene (data not
shown).
Using the convention established by Kropinski et. al.
[20], and electron microscopic observations, this virus
was formally called vB_EcoS_Rogue1, but will subse-
quently be referred to as Rogue1 in this manuscript.
Electron microscopy
Negatively-stained preparations of phage Rogue1 displayed
typical siphovirus morphology with long, relatively rigid
(152 x 8 nm) noncontractile tails (Figure 2). Tail striations
have a periodicity of 3.5 nm and terminated in short
Table 1 E. coli strains used to assess the virulence of the three isolates of the rogue phage as determined by the
microplate virulence assay
Strain No. Serotype E. coli O157
Phage Type
Strain description Minimum Phage MOI1
LRCSh151d1 LRCSh158d1 LRCSh166d1
EC19990293 O157:H7 PT21 Phage type reference strain 0.00001 0.000001 0.000001
EC19990295 O157:H7 PT4 Phage type reference strain 0.00001 0.00001 0.000001
EC19990296 O157:H7 PT23 Phage type reference strain 0.000001 0.000001 0.00001
EC19990298 O157:H7 PT14 Phage type reference strain 0.00001 0.000001 0.000001
EC19990299 O157:H7 PT14 Phage type reference strain 0.01 0.00001 0.001
EC19990300 O157:H7 PT2 Phage type reference strain 0.0001 0.0001 0.00001
EC20010992 O7:H21 NA2 Non-pathogenic E. coli >10 >10 >10
EC19990779 O173:HUN NA Non-pathogenic E. coli >10 >10 >10
EC20030480 O157:H7 PT4 Challenge strain LRC.E318N 0.000001 0.000001 0.000001
EC20030479 O157:H7 PT1 Challenge strain LRC.E319 >10 >10 >10
EC20030478 O157:NM PT87 Challenge Strain LRC.E32511N 10 10 10
EC20030477 O157:H7 PT87 Challenge Strain LRC.H4420nal 0.000001 0.00001 0.000001
EC20030481 O157:H7 PT14 Challenge Strain LRC.R508N 0.00001 0.00001 0.000001
EC19940312 O157:H7 PT8 Challenge Strain LCDC.CO281–31nal 0.000001 0.0001 0.01
1 MOI: Multiplicity of Infection required for complete lysis of 1 CFU of the tested strains by the listed phages. Phages were identified as virulent for a bacterial
strain when the MOI was ≤10. 2 NA: not applicable. Description: Table (Microsoft Word).
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which curled up (data not shown). The heads measured
53 nm in diameter and displayed a constriction at the neck.Figure 2 Four representative electron micrographs of Rogue1 negativ
the family Siphoviridae with morphology reminiscent of coliphages λThese dimensions again closely resemble that of the cattle
rogue phage [18]. By comparison, the head of coliphage T1
is about 60 nm in diameter and the tail is 8 by 151 nm [21].ely stained with 1% uranyl acetate showing that they belong to
or T1.
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The genome size of Rogue1 was estimated to be 44.3 kb
by pulsed-field gel electrophoresis. Pyrosequencing has
become a routine and inexpensive way of sequencing
bacteriophage genomes. The sequence of phage Rogue1
resulted in two contigs of 12.8 (117 fold coverage) and
33.6 kb (99 fold coverage), respectively. Using custom
PCR primers we amplified and sequenced the missing
section resulting in collapse of the sequence data into a
single contig. In a similar manner, two 454 sequencing
induced frameshifts were corrected.
It was immediately recognized that the sequence of
Rogue1 was closely related to that of JK06 (NC_007291)
in that they shared genome size, mol%G + C and a single
arginyl-tRNA - Rogue1 (45.8 kb, 44.2 mol%G + C) and
JK06 (46.1 kb, 44.0 mol%G + C). For comparative pur-
poses, the completed sequence of Rogue1 was reordered
so that it began with the same nucleotide sequence
“acgcgtatatcaaat-agcac” as that of coliphage JK06. How-
ever, direct comparisons between Rogue1 and JK06
sequences were complicated due to numerous errors
contained in the JK06 sequence and its annotation. From
our perspective, JK06 contains 19 genes which should be
deleted, some of which are due to frameshifts. As a conse-
quence of the frameshifts, five of the JK06 genes should
therefore be reclassified as pseudogenes. A dotplot com-
parison of the two genomes presented in Figure 3 indicates
they are collinear. Using bl2seq [22] at http://blast.ncbi.
nlm.nih.gov/bl2seq/wblast2.cgi the alignment revealed nine
segments of >1 kb which showed 95-99% identity. Based
upon an analysis of 84.1% of the Rogue1 genome length,
the sequences are approximately 96.9% identical.
Bioinformatic analysis revealed the presence of 74
protein-encoding genes and an arginyl-tRNA (genomeFigure 3 Dotplot comparison of the genomes of Rogue1 and
JK06 showing essentially collinear genome sequences.position 3387-3462) recognizing the rare codon AGG [23].
The majority (62, 83.8%) of the proteins exhibit homology
to other T1-like phages, 26 of which have defined function
in DNA replication, morphogenesis, genome packaging
and lysis (see Additional file 1, Table S1).
Proteomics
The proteins of purified phage particles were resolved by
SDS-PAGE, revealing approximately six bands (Figure 4).
Proteomic analysis of the three indicated phage bands
(52.7 kDa, 30.5 kDa & 25.9 kDa) by MALDI QqTOF mass
spectrometry identified proteins that exactly matched the
predicted sequences of the proteins specified by genes 21,
22, and 29 (Additional file 2, Figure S1) revealing a high
sequence coverage of 59.5%, 83.5% and 53.7% in the
tryptic digests, respectively.
The gene for the major head protein specifies a 39.8 kDa
product, yet SDS-PAGE (Figure 4) revealed that this pro-
tein migrated with an estimated size of 30.5 kDa; and mass
spectrometry (Additional file 2, Figure S1; Additional file 3,
Table S2) did not reveal the N-terminal tryptic peptides.
These results suggest that the major capsid protein is enzy-
matically removed during morphogenesis, perhaps through
the action of the product of gene 18.
Analysis of the 57.8 kDa protein (Gp21) revealed four
repeats of the pentamer GPVGP. A ClustalW alignment
(Additional file 4, Figure S2) with its homolog phage JK06
protein YP_277466.1, which is incorrectly described as
“hypothetical DNA polymerase I,” reveals that these
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Figure 4 SDS-PAGE of phage Rogue1 structural proteins. Lanes
A and B contain samples of the virus while the lane labelled M has
the Fermentas PAGERuler.
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the presence of an intein, however using data on intein
structure from InBase (The Intein Database) [24] at
http://www.neb.com/neb/inteins.html showed none of the
residues usually associated with intein boundaries was
present.
Discussion
This example of ruminants acting as incubators for the
enrichment of pathogen-specific bacteriophages resem-
bles the studies from Bangladesh in which humans act
as incubators for Vibrio cholerae-specific phages [25,26].
These viruses presumably occur in the environment at
subdetectable levels and are enriched when a sufficiently
high host inoculum is provided. Similar situations in-
volving viruses active on phytopathogens where the eco-
systems adjacent to infected plants were reported to
have a higher concentration of specific phages than soil
or water from the vicinity of uninfected plants [27]. The
potential presence of enriched endemic bacteriophages
can make interpretation of the efficacy of a phage cock-
tail extremely problematic. In our case E. coli O157:H7-
inoculated sheep in a phage therapy trial were found to
shed a morphologically distinct phage which we have
characterized genomically and proteomically in this
manuscript. The emergence of an identical phage four
years later on the same facility [18] strongly suggests it
is endemic. Other endemic phages have been isolated
and characterized by Niu et al. [28,29] and Raya et al
[30]. These phages would not have been detected with-
out testing for phage shedding, a practice not typically
conducted in evaluation of other interventions. Conse-
quently, the potential impact of endemic phages on the
outcomes of any therapeutic trials would not be identi-
fied, an observation that supports the cautionary recom-
mendations for inclusion of phage testing in any in vivo
intervention studies (15).
In the Ninth Report of the International Committee on
Taxonomy of Viruses, the Siphoviridae are assigned to
eight bacteria-specific genera of viruses (Lambda-, PhiC31-,
c2-, L5-, N15-, SPbeta-, T1-, and T5-like viruses) and
one archaeal-specific genus represented by Methanobacter-
ium phage ΨM1 [31]. On the basis of DNA and protein
comparisons there is no doubt that coliphages JK06 and
vB_EcoS_Rogue1 belong to the “T1-like viruses” genus
along with coliphages Rtp [32], TLS [21], and phiEB49
(JF770475), Cronobacter phage ESP2949-1 [33], Enterobac-
ter aerogenes F20 (JN672684), Klebsiella phage KP36
(Z. Drulis-Kawa, personal communication), and Shigella
phage Shfl1 (NC_015456). Whole genome proteomic com-
parisons using CoreGenes [34] revealed that T1 shares 42
proteins in common with Rogue1 (53.8% similarity) with
the homologs generally evenly distributed except for the
first 18 and last six T1 genes for which no homologs existin Rogue1. Unfortunately, an accurate comparison of the
proteomes of JK06 and Rogue1 cannot be made due to the
errors found in the former sequence but their close similar-
ity in nucleotide sequence suggests that they are variants
of the same species. Here we have two phages which were
isolated in Israel (JK06) and Canada (vB_EcoS_Rogue1)
which are remarkably similar at the DNA level. A number
of other presumably related phages have recently been
characterized microscopically and on the basis of restric-
tion digestion profiles [29]. These observations indicate
that related phages are distributed globally as has been
shown previously with Pseudomonas phage PB1 [35] and
ϕKMV [36].
BLAST analysis on the proteins found in the tail re-
gion of phage Rogue1 resulted in the discovery of homo-
logs of coliphage lambda gpH, gpL and gpI. Homology
detection & structure prediction by HMM-HMM com-
parison (HHpred) analysis [37,38] revealed that Rogue1
genes 26, 28, and 29 specified proteins were structurally
related to lambda gpFII, gpU, and gpV. Moreover, the
arrangement of the lambda tail morphogenesis cluster
is identical to that of our phage with the exception
of the presence of gene 34. Based upon synteny, we
hypothesize that Rogue1 genes 27, 30, 31, 33 and 36 spe-
cify analogues of lambda gpZ, G, T, M and K. While
gene 30 does not possess the classical lambda frame-
shifting site (GGGAAAG) it does possess a downstream
pseudoknot structure and therefore during translation
may form a G-T-type fusion protein with gp31. Further-
more, part of Phyre2 [39] analysis of the potential 3D
structure of gp33 and accompanying PSI-BLAST search
indicated one of the hits was to UniRef50 (UniProt
NREF (UniProt Reference Clusters) database) [40,41]
P03737 (E-value: 3e-23). This protein is identified as
lambda minor tail protein M. While there is no prote-
omic evidence for the presence of gpI, L and M in the
tail of coliphage lambda [42] these proteins are indeed
involved in the assembly of the tail. These results col-
lectively provide a genetic basis for the morphological
quasi-identity of lambda and T1 that was noted in 1974
by Christensen [43]. Furthermore, in uranyl acetate,
lambda and T1 look absolutely identical; while in phos-
photungstate, the lambda tail is rather rigid and that of
T1 is extremely flexible (Ackermann, unpublished
results). The difference is clearly in the tail shaft protein.
Lastly, we were able to successfully model the structure
of 99 residues (40%) of Rogue1 gp36 (Additional file 5,
Figure S3.) with 100.0% confidence against a single high-
est scoring template (RCSB PDB number 2EVR). The
latter is putative gamma-D-glutamyl-l-diamino acid endo-
peptidase [44]. If this is part of the distal end of the phage
tail it may play a role in degradation of the peptidoglycan
sacculus during injection as noted with other phage tail
proteins [45-47].
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Experimental Animals and Treatments
Five Canadian Arcott rams (50.0 + 3.0 kg) were housed
in a separate room in a contained facility equipped with
its own feed bunk and water source. They were fed a
pelleted barley-based total mixed diet once daily and
were adapted to their environment for a period of seven
days prior to the start of the trial. During this time feces
of the five sheep were screened for E. coli O157:H7 and
E. coli O157:H7 phages by established enrichment meth-
ods [18]. None was detected. On Day 0, the sheep were
infected orally with 109 CFU of E. coli O157:H7 R508N,
a nalidixic acid-resistant phage type 14 strain, followed
on Days 4 and 5 by ruminal inoculation with 1010 PFU
of a cocktail of three lytic E. coli O157:H7 phages; rV5,
wV8 and wV7. Fecal samples collected from all sheep
daily for seven days then every second day to Day 22
were tested for E. coli O157:H7 and E. coli O157:H7
phages as described [18]. Care and use of the animals
throughout the study were approved by the Animal Care
Committee of the Lethbridge Research Centre of Agri-
culture and Agri-Food Canada under Animal Use Proto-
col 0344, and in accordance with guidelines established
by the Canadian Council on Animal Care (1993).
Isolation of Rogue phage
Feces from three of the five sheep tested on Day 5 con-
tained phages forming plaques with a 1 mm zone of clear
lysis and a large opalescent halo, distinctly different from
the 1-2 mm plaques of the administered phages that were
also present. These “rogue” phages were subsequently shed
by two or more sheep at each sampling between Days 5
and 18 at levels of ~101 to 104 PFU/g of feces, together
with the small plaque-forming administered phages at
levels of ~101 to 107 PFU/g. One of the rogue phages from
each of the three sheep on the first day of shedding was
isolated on R508N and were named LRCSh151d1(R508N),
LRCSh158d1(R508N), and LRCSh166d1(R508N), respect-
ively. They were subsequently propagated on strain R508N,
plated on nutrient agar and their unique plaque morph-
ology photographed.
Host-range study
After propagation, the host-ranges of the phages were
assessed using a microwell virulence assay [28] by incu-
bating 108 bacterial cells with 10-fold serial dilutions
(109 to 102) of each bacteriophage in Tryptic Soy Broth
(TSB: BD Canada, Mississauga ON, Canada). Following
a five hour incubation at 37°C, the minimum number of
phages required to completely lyse 1 CFU of the strain
was determined [28]. The tested strains included refer-
ence strains of E. coli O157:H7 phage types common in
Canada, two potential non-pathogenic E. coli host
strains (O7:H21 and O173:HUN) and six nalidixic acidresistant strains of E. coli O157:H7 planned for used for
multiple strain challenge studies (Table 1). Phages were
identified as virulent for a bacterial strain when the MOI
was equal to or less than 10.
Electron microscopy
A purified sample of phage was diluted 1:1 with distilled
water and 10 μL were immediately transferred to a for-
mvar/carbon coated copper grid. Excess sample was
wicked off with filter paper and the grid was stained for
20 sec. with 1% uranyl acetate (aq). Excess stain was
removed using filter paper and the grid was allowed to
dry before putting it into the microscope. The photo-
graphs were taken on the LEO912AB transmission EM
at 100 kV using a Cantega 2 K camera.
Purification, DNA isolation and DNA sequencing
The phage was batch cultivated in 2.0 L of Trypticase
soy broth containing 10 mM MgSO4 for 18 h at 37°C
with shaking at 120 rpm. The resulting lysate was clari-
fied by centrifugation (6,000 x g), treated with DNase 1
and RNase A (Sigma Aldrich Canada Ltd., Oakville, ON)
and concentrated by 10% w/v polyethylene glycol pre-
cipitation [48]. The phage was purified through two
rounds of CsCl equilibrium gradient centrifugation as
described in [49], followed by dialysis and spectrophoto-
metric quantitation.
DNA was isolated from LRCSh151d1(R508N) using
the standard phenol-chloroform extraction protocol
[49]. The DNA was subjected to pyrosequencing at the
McGill University and Genome Québec Innovation
Centre (Montreal, QC, Canada) resulting in two contigs.
The 90 bp gap was closed by PCR amplification using
custom primers and ABI sequencing at the University of
Guelph Laboratory Services (Guelph, ON, Canada). Two
genome regions suggesting frameshifts were also investi-
gated by PCR and amplicon sequencing.
In addition the genome size was estimated by pulsed
field gel electrophoresis [50].
Annotation and comparative genomics
Protein-encoding genes for phage vB_EcoS_Rogue1
were identified using Kodon (Applied Maths, Austin,
TX), while tRNAscan-SE [51] and ARAGORN [52] were
used to identify tRNA genes. All proteins were checked
for homologs against the nonredundant database at
NCBI using Batch-BLAST (http://greengene.uml.edu/
programs/ NCBI_Blast.html). Protein motifs were exam-
ined using Pfam [53], TMHMM [54] and Phobius [55].
In the case of conserved hypothetical proteins they were
analyzed using HHpred at http://toolkit.tuebingen.mpg.
de/hhpred and for tertiary structure using Phyre2 [39].
Rho-independent terminators were discovered using Trans-
Term [56] at http://nbc11.biologie.uni-kl.de/framed/left/
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on the basis of homology to the consensus sequence (TT
GACA(N15-17)TATAAT) of sigma70(RpoD)-dependent E.
coli promoters using DNAMAN (Lynnon Corp., Pointe-
Claire, QC, Canada).
For comparative purposes pairs of phage DNA sequences
were aligned using Advanced Pipmaker [57] and MAUVE
[58]; while the proteomes were compared using Core-
Genes [34].
PCR analysis of putative tail fibre genes
Two primers (JK-75-F, 5’-TAGGAA TGCCGGAAACTG
TAGGAT and JK-75-R, 5’-CGTTTGCTGGCTTAATTCT
TG TCT) based upon orf75 of phage JK06 (NC_007291)
were used with 1X PCR buffer, 400uM dNTPs, 3.5 mM
MgCl2, 300nM primers, and 0.05U/ul Taq polymerase
(Applied Biosystems, Branchburg, NJ, USA) under the
standard to amplify a 509 bp product from the rogue
phage genomes.
GenBank accession number
The sequence of phage vB_EcoS_Rogue1 was exported
from Kodon and subjected to a conversion using
gbk2sqn (http://lfz.corefacility.ca/gbk2sqn/) prior to sub-
mission to NCBI. The accession number for genome se-
quence of phage vB_EcoS_Rogue1 is JQ182736.
Proteomics
CsCl-purified phage particles were subjected to SDS-
PAGE [59] on precast 4-15% gradient TRIS acrylamide
gels (BioRad) along with the PageRuler Unstained Pro-
tein Ladder (Fermentas, Burlington, ON, Canada). The
gels were stained with SimplyBlue SafeStain (Invitrogen)
and analyzed using BioNumerics software (Applied
Maths). For more detailed proteomic analysis individual
phage bands were excised from the gels and digested
with trypsin as described previously [60]. In brief, the
protein bands were first destained with 100 mM ammo-
nium bicarbonate (NH4HCO3)/acetonitrile (ACN) (1:1,
v/v) until colorless, then followed by reduction with
10 mM dithiothreitol (DTT) at 56°C and alkylation with
55 mM iodoacetamide in 100 mM NH4HCO3 solution.
Subsequent digestion was performed using 10 ng of se-
quencing grade trypsin (Calbiochem, San Diego, CA) in
25 mM NH4HCO3 (pH 7.6) at 37°C overnight. The
resulting peptide digests were extracted by successive
sonication with 0.1% TFA and 0.1% TFA in 60% ACN,
and dried in the Savant SpeedVac concentrator. After
C18 Ziptip (Millipore) cleaning, the tryptic peptides were
analyzed by matrix-assisted laser adsorption ionization
(MALDI) mass spectrometry using 2,5-dihydroxybenoic
acid matrix (100 mg/ml in 50% ACN). All mass spectrom-
etry (MS) experiments were carried out on a Applied Bio-
systems/MDS Sciex QStar XL QqTOF mass spectrometerequipped with oMALDI II source and a nitrogen UV
laser (337 nm). Following MS mapping, tandem MS/MS
sequencing was routinely performed on the individual
peptides at low-energy CID using argon as the collision
gas. Protein identification was achieved by Mascot data-
base search (http://www.matrixscience.com) with the
masses of either single MS peptide mass fingerprinting or
MS/MS fragments based on the NCBI nonredundant
database and the in-house Escherichia coli O157:H7
phage Rogue1 database. The search parameter settings
allowed trypsin digestion for maximum 2 missed cleav-
age sites, and carbamidomethylation of cysteine as a fixed
modification. Deamidation of asparagine and glutamine,
oxidation of methionine, and loss of methionine at pro-
tein N-terminus were considered as variable modifica-
tions. Mass tolerances were set up to 0.1 Da for both MS
andMS/MS fragment ions.
Additional files
Additional file 1: Table S1. Properties of the proteins encoded by
phage Rogue1.
Additional file 2: Figure S1. Mass spectral analysis of three Rogue1
structural proteins.
Additional file 3: Table S2. Protein sequence identification of Rogue1
phage by MS/MS measurements of the peptides and database search.
Additional file 4: Figure S2. ClustalW alignment of Rogue1 gp21 with
its homolog phage JK06 protein YP_277466.1. The pentameric repeats
are indicated in bold and green.
Additional file 5: Figure S3. 3D structure of a portion of gp36 based
upon template c2fg0B, determined using Phyre2 [39].
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